Skip to main content
Sign in
Menu
Membership
Events
Knowledge Center
About
Register
Search
Sign In
Sign In
Register
Subscribe
Premium
Alternative Insight and Premium Journalism
Latest Articles
For Members Only
Prominent Hedge Funds Stand to Benefit From Biopharma’s Change of Plans
Stephen Taub
December 6, 2023
For Members Only
Biopharma Bonanza
Stephen Taub
December 5, 2023
For Members Only
Greenlight Suffers a Setback in November
Stephen Taub
December 4, 2023
For Members Only
Soleus Goes Activist
Stephen Taub
November 30, 2023
For Members Only
Hedge Funds Eye Next Biopharma IPO
Stephen Taub
November 29, 2023
For Members Only
Deerfield Launches New VC Fund
Stephen Taub
November 28, 2023
For Members Only
Narrow Trade
Stephen Taub
November 27, 2023
For Members Only
Hedgies Shop for Instacart
Stephen Taub
November 22, 2023
For Members Only
Stan Druckenmiller Condolidates His Stock Holdings
Stephen Taub
November 21, 2023
For Members Only
Third Point’s Credit Bet
Stephen Taub
November 20, 2023
For Members Only
A Look Into Tiger Descendants’ Activity in the Third-Quarter
Stephen Taub
November 16, 2023
For Members Only
TCI, Whale Rock and Other Hedge Funds Made Major Moves in the Third-Quarter
Stephen Taub
November 15, 2023
For Members Only
Casdin Leads Ailing Life Sciences Fund Losses
November 14, 2023
For Members Only
Bridgewater Launches Two Funds
Stephen Taub
November 13, 2023
For Members Only
Greenlight Sharply Cuts Its Market Bet
Stephen Taub
November 9, 2023
For Members Only
Icahn’s Investment Fund Plunges Deeper Into the Red
Stephen Taub
November 8, 2023
For Members Only
Third Point Slashes Market Exposure
Stephen Taub
November 7, 2023
For Members Only
Citadel Continues to Set the Pace
Stephen Taub
November 6, 2023
More Articles